Difference between revisions of "Bertran Auvert"
Jump to navigation
Jump to search
m (using {{#tip-text}} for abbreviations and acronyms now) |
m (reformat and tidy up REF...s) |
||
| Line 18: | Line 18: | ||
|} | |} | ||
| − | Bertran Auvert is a biased pro-circumcision researcher of French origin who has been a circumcision proponent since at least 2003.<ref>Rain-Taljaard | + | Bertran Auvert is a biased pro-circumcision researcher of French origin who has been a circumcision proponent since at least 2003.<ref>{{REFjournal |
| − | {{REFjournal | + | |last=Rain-Taljaard |
| + | |first=R.C. | ||
| + | |last2=Lagarde | ||
| + | |first2=E. | ||
| + | |last3=Taljaard | ||
| + | |first3=D.J. | ||
| + | |last4=Campbell | ||
| + | |first4=C. | ||
| + | |last5=MacPhail | ||
| + | |first5=C. | ||
| + | |last6=Williams | ||
| + | |first6=B. | ||
| + | |last7=Auvert | ||
| + | |first7=B. | ||
| + | |author7-link=Bertran Auvert | ||
| + | |title=Potential for an intervention based on male circumcision in a South African town with high levels of HIV infection | ||
| + | |journal=Aids Care | ||
| + | |year=2003 | ||
| + | |volume=15 | ||
| + | |issue=3 | ||
| + | |pages=315-327 | ||
| + | }}</ref> Auvert was responsible for one of the three latest African circumcision trials,<ref name="Auvert PLoS">{{REFjournal | ||
|last=Auvert | |last=Auvert | ||
|first=Bertran | |first=Bertran | ||
| + | |author-link=Bertran Auvert | ||
|first2=Dirk | |first2=Dirk | ||
|last2=Taljaard | |last2=Taljaard | ||
| Line 35: | Line 57: | ||
|title=Randomized, Controlled Intervention Trial of Male Circumcision for Reduction of HIV Infection Risk: The ANRS 1265 Trial | |title=Randomized, Controlled Intervention Trial of Male Circumcision for Reduction of HIV Infection Risk: The ANRS 1265 Trial | ||
|journal=PLoS Med | |journal=PLoS Med | ||
| − | |volume= | + | |volume=2 |
|issue=November 2005 | |issue=November 2005 | ||
| − | |pages= | + | |pages=e298 |
|url=http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.0020298 | |url=http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.0020298 | ||
|accessdate=2011-03-03 | |accessdate=2011-03-03 | ||
| − | }}</ref> which are being used by the [[WHO|World Health Organization]] to endorse circumcision as an HIV prevention method.<ref> | + | }}</ref> which are being used by the [[WHO|World Health Organization]] to endorse circumcision as an HIV prevention method.<ref>{{REFweb |
| − | {{REFweb | ||
|last=World Health Oranization | |last=World Health Oranization | ||
|first= | |first= | ||
| Line 49: | Line 70: | ||
|url=http://www.who.int/hiv/topics/malecircumcision/en/index.html | |url=http://www.who.int/hiv/topics/malecircumcision/en/index.html | ||
|accessdate=2011-03-03 | |accessdate=2011-03-03 | ||
| − | }}</ref> He associates with the [[Gilgal Society]],<ref> | + | }}</ref> He associates with the [[Gilgal Society]],<ref>{{REFweb |
| − | {{REFweb | ||
|last=Morris | |last=Morris | ||
|first=Brian | |first=Brian | ||
| + | |author-link=Brian J. Morris | ||
|coauthors=Vernon Quaintance | |coauthors=Vernon Quaintance | ||
|date=2007 | |date=2007 | ||
| Line 61: | Line 82: | ||
|publisher=The Gilgal Society | |publisher=The Gilgal Society | ||
}} | }} | ||
| − | </ref> and is good friends with [[Bill Gates]].<ref> | + | </ref> and is good friends with [[Bill Gates]].<ref name="Lyons 2010">{{REFweb |
| − | {{REFweb | ||
|last=Lyons | |last=Lyons | ||
|first=Daniel | |first=Daniel | ||
| Line 78: | Line 98: | ||
|title=The Use of Male Circumcision to Prevent HIV Infection | |title=The Use of Male Circumcision to Prevent HIV Infection | ||
|date=2008 | |date=2008 | ||
| − | |publisher=Doctors Opposing Circumcision | + | |publisher=[[Doctors Opposing Circumcision]] |
|quote=...funding from the United States National Institutes of Health to conduct randomized controlled trials (RCTs) in Africa. | |quote=...funding from the United States National Institutes of Health to conduct randomized controlled trials (RCTs) in Africa. | ||
|accessdate=2011-03-05 | |accessdate=2011-03-05 | ||
}} | }} | ||
| − | </ref> was carried out in Orange Farm, South Africa under the supervision of Bertran Auvert.<ref | + | </ref> was carried out in Orange Farm, South Africa under the supervision of Bertran Auvert.<ref name="Auvert PLoS"/> The British medical journal the Lancet decided against publishing Bertran's study. Lancet officials, following standard policy at the journal, refused to comment on why the study was turned down.<ref>{{REFnews |
| + | |last=Schoofs | ||
| + | |first=M. | ||
| + | |last2=Lueck | ||
| + | |first2=S | ||
| + | |last3=Phillips | ||
| + | |first3=M.M. | ||
| + | |date=2005-07-05 | ||
| + | |title=Study says circumcision reduces AIDS risk by 70% | ||
| + | |publishere=The Wall Street Journal | ||
| + | |pages=A1 | ||
| + | }}</ref> | ||
In a Medscape interview, Bertran was asked, "in the group of men who were circumcised, I understand from the presentation that they were advised not to engage in sexual relations for approximately 5 weeks in order to recovery from the surgery. Is that correct?" Bertran replied, "Yes. We were very careful to recommend them to abstain from sex for 44 days, which is about 6 weeks after the surgical procedure, in order that they didn't have any risk of getting infected by HIV during this healing period." | In a Medscape interview, Bertran was asked, "in the group of men who were circumcised, I understand from the presentation that they were advised not to engage in sexual relations for approximately 5 weeks in order to recovery from the surgery. Is that correct?" Bertran replied, "Yes. We were very careful to recommend them to abstain from sex for 44 days, which is about 6 weeks after the surgical procedure, in order that they didn't have any risk of getting infected by HIV during this healing period." | ||
| Line 104: | Line 135: | ||
|Author=Bill Gates: Discussing Bertran's Circumcision "Studies" | |Author=Bill Gates: Discussing Bertran's Circumcision "Studies" | ||
|Source=Newsweek | |Source=Newsweek | ||
| − | |ref=<ref | + | |ref=<ref name="Lyons 2010"/> |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
}} | }} | ||
Revision as of 18:28, 5 November 2019
|
| Associates with: |
| Gilgal Society |
| Member of: |
| Bill & Melinda Gates Foundation |
| Colleagues & Benefactors: |
| Ronald H. Gray Stephen Moses Robert C. Bailey Brian J. Morris Bill Gates |
 Bill Gates, Bertran Auvert, Dirk Taljaard, Cynthia Nhlapo |
Bertran Auvert is a biased pro-circumcision researcher of French origin who has been a circumcision proponent since at least 2003.[1] Auvert was responsible for one of the three latest African circumcision trials,[2] which are being used by the World Health Organization to endorse circumcision as an HIV prevention method.[3] He associates with the Gilgal Society,[4] and is good friends with Bill Gates.[5]
Contents
Auvert's Circumcision Study
An RCT funded by the United States National Institutes of Health (NIH)[6] was carried out in Orange Farm, South Africa under the supervision of Bertran Auvert.[2] The British medical journal the Lancet decided against publishing Bertran's study. Lancet officials, following standard policy at the journal, refused to comment on why the study was turned down.[7]
In a Medscape interview, Bertran was asked, "in the group of men who were circumcised, I understand from the presentation that they were advised not to engage in sexual relations for approximately 5 weeks in order to recovery from the surgery. Is that correct?" Bertran replied, "Yes. We were very careful to recommend them to abstain from sex for 44 days, which is about 6 weeks after the surgical procedure, in order that they didn't have any risk of getting infected by HIV during this healing period." [8] Later in the interview he says "We also have 2 ongoing trials in Uganda and Kenya." (Notice the word "We" here.)
Publications
Bill Gates
| “ | Bertran Auvert, is so modest about his work, but he has new theories that we're putting money behind and he is just making it work. – Bill Gates: Discussing Bertran's Circumcision "Studies" (Newsweek)[5] |
See also
- Gilgal Society -- Auvert associates with this circumfetish group.
- Bill & Melinda Gates Foundation -- Auvert is on the staff.
- Bill Gates -- Colleague & Benefactor of Auvert.
- Ronald H. Gray -- Colleague & Benefactor of Auvert.
- Stephen Moses -- Colleague & Benefactor of Auvert.
- Robert C. Bailey -- Colleague & Benefactor of Auvert.
- Brian J. Morris -- Colleague & Benefactor of Auvert.
- National Institutes of Health -- Funded Auvert's study.
- World Health Organization -- Endorces Auvert's study.
External links
- Gilgal Society Association -- Auvert contributed to a brochure created by Gilgal Society.
References
- ↑
Rain-Taljaard, R.C., Lagarde, E., Taljaard, D.J., Campbell, C., MacPhail, C., Williams, B., Auvert, B.. Potential for an intervention based on male circumcision in a South African town with high levels of HIV infection. Aids Care. 15(3): 315-327.
- ↑ a b Auvert, Bertran, Taljaard, Dirk, Lagarde, Emmanuel, Sobngwi-Tambekou, Joëlle, Sitta, Rémi, Puren, Adrian. Randomized, Controlled Intervention Trial of Male Circumcision for Reduction of HIV Infection Risk: The ANRS 1265 Trial. PLoS Med. 25 October 2005; 2(November 2005): e298. Retrieved 3 March 2011.
- ↑
World Health Oranization. WHO Male circumcision for HIV prevention
. Retrieved 3 March 2011. - ↑ Morris, Brian (2007).
Sex and Circumcision What every Woman needs to know
, The Gilgal Society. Retrieved 27 February 2011.
- ↑ a b Lyons, Daniel (25 January 2010).
Saving The World, 2.0
, Newsweek, Harman Newsweek LLC. Retrieved 3 March 2011. - ↑
(2008)."The Use of Male Circumcision to Prevent HIV Infection", Doctors Opposing Circumcision. Retrieved 5 March 2011.
Quote:...funding from the United States National Institutes of Health to conduct randomized controlled trials (RCTs) in Africa.
- ↑ Schoofs, M. / S Lueck / M.M. Phillips (5 July 2005)."Study says circumcision reduces AIDS risk by 70%".
- ↑ Medscape (29 July 2005).
Randomized Clinical Trial Shows Male Circumcision Has Great Potential to Curb HIV Infections in Africa
, Medscape. Retrieved 3 March 2011.
